Vertex Pharmaceuticals Incorporated
DE ˙ XTRA ˙ US92532F1003
368,15 € ↑3,40 (0,93%)
2026-06-04
CENA AKCJI
SecurityDE:VX1 / Vertex Pharmaceuticals Incorporated
InstitutionNorges Bank
Latest Disclosed Ownership3,176,613 shares
Latest Disclosed Value $ 1,440,149,270
Norges Bank ownership in VX1 / Vertex Pharmaceuticals Incorporated

On February 10, 2026 - Norges Bank filed a 13F-HR form disclosing ownership of 3,176,613 shares of Vertex Pharmaceuticals Incorporated (DE:VX1) valued at $1,236,020,118 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $1,169,470,076 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-10 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,176,613 3,176,613 1,440,149 0.1541
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -3,580,356 -100.00 0 -100.00
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,580,356 216,206 6.43 1,593,974 -2.27 0.1990
2026-05-11 2025-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 3,364,150 -50,174 -1.47 1,631,007 18.62 0.2289
2025-02-12 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,414,324 4,542 0.13 1,374,948 -13.30 0.1804
2025-11-12 2024-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 3,409,782 -19,304 -0.56 1,585,821 -1.34 0.2215
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,429,086 -28,864 -0.83 1,607,281 11.20 0.2401
2025-05-14 2024-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 3,457,950 415,662 13.66 1,445,458 16.77 0.2281
2024-02-09 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,042,288 368,382 13.78 1,237,877 33.13 0.2163
2024-11-13 2023-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,673,906 64,995 2.49 929,824 1.28 0.1887
2024-08-14 2023-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,608,911 79,972 3.16 918,102 15.22 0.1812
2024-05-15 2023-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,528,939 77,418 3.16 796,793 12.55 0.1744
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,451,521 163,049 7.12 707,950 6.84 0.1706
2023-11-13 2022-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,288,472 61,874 2.78 662,604 5.61 0.1762
2023-08-14 2022-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,226,598 -398,150 -15.17 627,433 -8.40 0.1622
2023-05-12 2022-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,624,748 -55,151 -2.06 684,980 16.39 0.1493
2022-03-09 2021-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,679,899 153,719 6.09 588,506 28.43 0.1210
2022-11-14 2021-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,526,180 -21,250 -0.83 458,224 -10.79 0.1014
2022-08-15 2021-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,547,430 -90,096 -3.42 513,638 -9.38 0.1113
2022-05-09 2021-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,637,526 -133,800 -4.83 566,778 -13.47 0.1298
2021-03-02 2020-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,771,326 -90,928 -3.18 654,975 -15.91 0.1529
2021-11-12 2020-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,862,254 175,851 6.55 778,877 -0.13 0.2069
2021-08-13 2020-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,686,403 148,490 5.85 779,890 29.14 0.2245
2021-05-07 2020-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,537,913 20,310 0.81 603,896 9.55 0.2152
2020-03-03 2019-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,517,603 135,224 5.68 551,229 36.57 0.1538
2020-11-13 2019-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,382,379 0 0.00 403,623 -7.61 0.1236
2020-08-13 2019-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,382,379 0 0.00 436,881 -0.31 0.1350
2020-05-11 2019-03-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 2,382,379 85,698 3.73 438,239 15.15 0.1416
2019-03-04 2018-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,296,681 -27,323 -1.18 380,584 -15.03 0.1416
2019-12-02 2018-09-30 13F/A-3 VERTEX PHARMACEUTICALS COM 92532F100 2,324,004 -41,203 -1.74 447,928 11.43 0.1455
2019-12-02 2018-09-30 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 2,324,004 -41,203 447,928 0.1455
2019-11-12 2018-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,324,004 -41,203 447,928 0.1455
2019-08-12 2018-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,365,207 -69,449 -2.85 401,992 1.31 0.1380
2019-05-15 2018-03-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 2,434,656 94,152 4.02 396,800 13.13 0.1436
2018-03-05 2017-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,340,504 191,180 8.89 350,748 7.33 0.1257
2018-11-13 2017-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,149,324 125,272 6.19 326,783 25.28 0.1240
2018-07-24 2017-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,024,052 -127,869 -5.94 260,840 10.85 0.1035
2018-05-11 2017-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 2,151,921 420,366 24.28 235,312 84.47 0.0966
2017-03-02 2016-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,731,555 56,502 3.37 127,564 -8.57 0.0558
2017-11-13 2016-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,675,053 0 0.00 139,524 -3.17 0.0659
2017-08-09 2016-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,675,053 -45,441 -2.64 144,089 5.36 0.0685
2017-05-10 2016-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,720,494 -53,627 -3.02 136,763 -38.74 0.0673
2016-04-18 2015-12-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 1,774,121 4,715 0.27 223,237 21.15 0.1110
2016-03-16 2015-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,774,121 0 223,237 0.1120
2016-11-14 2015-09-30 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 1,769,406 124,052 7.54 184,266 -9.30 0.0966
2016-08-12 2015-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,645,354 49,305 3.09 203,169 7.90 0.1015
2016-05-13 2015-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,596,049 -15,131 -0.94 188,287 -1.63 0.0923
2015-03-19 2014-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,611,180 70,910 191,409 0.0976
2016-04-18 2014-12-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 1,611,180 70,910 4.60 191,409 10.65 0.0973
2015-11-12 2014-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,540,270 0 0.00 172,988 18.62 0.0937
2015-08-10 2014-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,540,270 7,438 0.49 145,833 34.53 0.0787
2015-05-12 2014-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,532,832 0 0.00 108,402 -4.82 0.0612
2014-03-07 2013-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,532,832 -371,911 113,889 0.0697
2014-03-20 2013-12-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 1,532,832 0 113,889 0.0670
2014-05-12 2013-12-31 13F/A-3 VERTEX PHARMACEUTICALS COM 92532F100 1,532,832 -371,911 -19.53 113,889 -21.14 0.0656
2014-11-14 2013-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,904,743 1,037,398 119.61 144,417 108.47 0.0843
2014-08-14 2013-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 867,345 205,472 31.04 69,275 90.37 0.0430
2014-04-04 2013-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 661,873 -866,290 36,390 0.0241
2014-05-12 2013-03-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 661,873 -866,290 -56.69 36,390 -55.36 0.0236
2013-11-14 2012-09-30 13F/A-1 VERTEX PHARMACEUTICALS I COM 92532F100 1,528,163 729,840 91.42 81,524 110.51 0.0549
2013-08-15 2012-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 798,323 798,323 38,727 0.0311
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.